Introduction
HIV is a multifactorial infection, representing a lifetime long fi ght between the causative agent -Human Immunodefi ciency Virus (HIV) and the host (6) . Similarly to other retroviral infections, the intensive research on HIV-replication dynamics in vivo during the last years has clearly defi ned both viral and human/host factors infl uencing transmission, course, progression and outcome of infection (6, 11) .
HIV-transmission depends on biological properties of viral strains, as well as on the individual susceptibility. On the other hand, the latter is closely associated to a range of immunological and genetic factors. Among those, a number of chemokine receptors have been identifi ed to function as co-receptors for HIV-1 entry in human CD4+ T-lymphocytes and monocytes (16) . CCR5 is a chemokine receptor, whose α-chemokine ligands participate in chemotaxis of lymphocytes during infl ammation. CCR5-protein is expressed on the surface of monocytes, macrophages, memory T-cells and dendritic cells, as well as on microglial cells correlating to the ability of HIV to infect the central nervous system (7) . This is the major co-receptor, necessary for macrophage-tropic (Mtropic) non-syncytium inducing (NSI) HIV-1 strains entry (5) . A complicated interaction between HIV-1 glycoprotein gp120, CD4 and CCR5 on the surface of CD4+ cells is crucial to HIV entry. As known, М-tropic strains are associated predominantly with sexual transmission of HIV. Detailed studies of the coding region of CCR5 showed a variety of genetic polymorphisms. 32-base pair deletion (CCR5del32 mutation) in one or both alleles seems the most common polymorphism. When occurring in both alleles (homozygous pattern), this polymorphism leads to a formation of truncated, non-functional receptor protein, incapable to bind gp120 during the adhesion of HIV to the cell (20) . The same mutation could also exist in only one allele (heterozygous pattern), leading to a limited production of the functional protein.
The homozygous (CCR5del32/CCR5del32) individuals were reported insusceptible to infection with М-tropic HIV-1 strains (8) . Data showed that heterozygous (CCR5del32/ CCR5) individuals had better prognosis during natural course of infection compared to those bearing "wild type" (CCR5/ CCR5) alleles. The individuals with heterozygous pattern show a decreased expression of CCR5 on the cell surface and are more frequently considered as Long Term Non Progressors (LTNPs) compared to patients with a rapid/moderate progression of infection (4) . In addition, HIV-infected heterozygous individuals also demonstrate better response to Highly Active Anti Retroviral Therapy (HAART) and decreased lymphoma incidence (19) . These data clearly indicate that CCR5 density on cell surface could be a limiting factor for HIV-replication both in vitro and in vivo. (23) .
GENETIC POLYMORPHISM OF THE CHEMOKINE CO-RECEPTORS CCR5, CXCR4 AND CCR2 IN BULGARIANS LIVING WITH HIV
CCR2 is the next chemokine co-recеptor participating in chemotaxis between lymphocytes and extrinsic agents, analogous to CCR5. The coding gene is located in proximity to that of CCR5, therefore the two genes are co-inherited. An amino acid replacement (CCR2 V64I) has been studied in relation to progression to AIDS. Comparison of individuals displaying wild types of CCR5 and CCR2 to those with homo-and/or hetero-zygous patterns of both genes display considerable delay of progression of HIV-infection, but mostly in presence only of non-sincytium inducing (NSI; М-tropic) HIV-1 variants. In heterozygous CCR2 V64I patients with genetic defects in CCR5 a predominance of syncytium inducing (SI; T-tropic) HIV-1 variants is observed. This fact shows that the infl uence of CCR2 polymorphism is extended over CCR5-exploring HIV-variants (18) .
Genetic restrictions of HIV-1 infection and progression to AIDS requires meeting of criteria for Long Term Non Progressors (LTNPs) and Long Term Survivors (LTSs). A number of authors defi ne LTNPs as asymptomatic for 10 or more years, with normal absolute CD4 T cell counts, below detection viral loads and remaining therapy naive. LTSs are individuals who have been infected with HIV also for several years (typically 7-10 or more years), with a damaged immune system and/or opportunistic infections and receiving therapy (2) . Some authors include LTNPs in the group of LTSs (2). According to literature, 5-10% of all people living with HIV fall into the LTNP category, displaying no evidence of disease progression despite 10-15 years of documented HIV-infection (3, 10, 15) .
Since it is clear that genetic factors infl uence both natural course of infection and presumably the response to HAART, it has been hypothesized that the effect of therapy could be to some extent genetically determined (14) . This fact raises the need for a further study of chemokine co-receptors in persons, living with HIV and receiving HAART.
Here, for the fi rst time, we describe the most spread genetic polymorphisms of the chemokine co-receptors CCR5, CXCR4 and CCR2 -namely the allele frequency of CCR5del32, SDF-1 3'A and CCR2 V64I in 177 Bulgarians living with HIV, as well as the correlation of the results to the clinical course of HIVinfection and the same allele frequency for general population. Earlier, when we started studies of the same genetic factors (1) we considered 9 persons as LTNPs. During the following years their HIV disease progressed toward immune defi ciency and they were given HAART. We believe this could be a reason for revision and addition of new genetic data linked to the course of infection. Today we consider these persons LTSs, not LTNPs. The second reason to present the current results and to compare them to those for general population is the fact that no or limited genetic co-receptors polymorphism data are published for the South-East European region (Balkan countries) (14) . Such data would be of interest, because population migration in this district has occurred during last centuries quite often. Also, minority populations studied by us earlier (21) live in relative isolation although often migrating.
Additionally, it has been recently demonstrated that the protection effect of CCR5del32 and CCR2 I64V alleles on HIV-1 disease progression varies with duration of infection (15) . All this encouraged us to study further the impact of host genetic factors in HIV disease.
Here we describe for the fi rst time the most spread genetic polymorphisms of CCR5, CXCR4 (SDF-1) and CCR2 and their combinations in Bulgarians living with HIV with differing clinical course of infection.
Materials and Methods

Patient population
In this study 177 Bulgarians, living with HIV with different duration of infection were included, 14 out of them (7.9%) were clinically detected as LTSs. The blood samples (Gutrie cards) were taken in the Hospital of Infectious Diseases, Sofi a. All participants were studied for CCR5del32 polymorphism and 48 out of them (only 11 LTSs for genetic polymorphisms of CXCR4 SDF-1 (SDF-1 3'A) and CCR2 (CCR2 V64I).
The following control groups were studied: 1. a representative group for CCR5del32 genetic polymorphism. The group consists of 900 Bulgarian residents. 2. a non-representative group for CXCR4 (SDF-1 3'A) including 100 Bulgarians chosen randomly. No control group for CCR2 polymorphism in non-infected persons is represented in this paper.
Genetic analysis
For genetic analysis of all samples Gutrie cards with peripheral blood samples were used. First, direct DNA amplifi cation from dried blood spots punched from the Gutrie cards without prior DNA extraction was tried. The results obtained however were inconclusional, so DNA-extraction had to be undertaken.
DNA was isolated from Gutrie cards using phenol: chloroform: isoamyl alcohol (25:24:1) method according to protocol described elsewhere.
To study CCR5 genetic polymorphism extracted DNA (50-100ng/μl) was amplifi ed by PCR according to previous adaptation (not published) and the amplifi cation products further were analyzed and visualized in horizontal 3% agarose gel-electrophoresis. This agarose gel could separate between 198bp (wild type) and 166bp (homo-or heterozygous pattern). The primers used were according to (16) .
For study of CXCR4 (SDF-1) genetic polymorphisms, restriction analysis with the restrictase MspI (18) following the PCR amplifi cation was performed followed by horizontal 3% agarose gel-electrophoresis. The SDF-1 3'A mutation alters the specifi c site for MspI restrictase, thus preventing it from cleaving the 294bp PCR product. The agarose gel could separate between 101bp, 193 (wild type) and 294bp (SDF -1 3'A).The primers used were according to (18) .
The CCR2 genetic polymorphisms were also studied by restriction analysis with the restrictase Bsa BI (22) following the PCR amplifi cation. Analysis was then performed by 8% polyacrylamide gel-electrophoresis. The CCR2 V64I mutation creates site, recognized by Bsa BI restrictase. The latter cleaves the 128bp PCR product, creating 110bp fragment. The polyacrylamide gel could separate between 128bp (wild type) and 110bp (CCR2 V64I). The primers used were according to (22) .
Statistical methods
Zero Hypothesis (H 0 ) was used to compare the frequencies studied. Initially this method determines fi rst the Signifi cance level (α) for this data. This parameter represents the risk to discard H 0 , even if true. In our study we used α = 0.05 (5%).
The probability P was then estimated. When P>α, H 0 is accepted, i.e. there is no statistically signifi cant difference between compared groups. When P<α, H 0 is discarded, i.e. there is statistically signifi cant difference between compared groups.
The P value depends on the parameter χ 2 . Standard variation analysis software was used for calculating of χ 2 and P for the results obtained for allelic and genotype frequencies. Fig. 1 shows different patterns of CCR5 genetic polymorphism -amplifi cation products of 198bp and 166bp in 3% agarose-gel electrophoresis. Totally, among 177 persons, living with HIV, none had CCR5del32 homozygous status, six out of them showed heterozygocity (only three -LTSs) and 171 -"wild type". The CCR5del32 allelic frequency was 1.7%. The fact that nobody among those living with HIV was found with homozygous pattern of CCR5 (CCR5del32/CCR5del32) confi rms the data reported about genetic insusceptibility of these individuals to НІV-infection (8 On the other hand, it is evident that the heterozygous CCR5 profi le is not the only one responsible for the slow progression to AIDS. Six persons out of all studied (3.4%) were found with heterozygous CCR5del32 genotype, but only 3 out of them belonged to LTSs (Column B). This fact shows that although linked to slow progression of HIV-infection, this polymorphism is not the only one, associated with this clinical condition. Therefore, this research should be extended and further study of polymorphism of other human genetic factors should be included in order to clarify the clinical signifi cance of different genetic polymorphism combinations. Additionally, it becomes also clear that the heterozygous CCR5 profi le is not typical for the individuals with rapid/moderate progression (Column B vs. C -p < 0.05).
Results and Discussion
CCR5 genetic polymorphism
It was of interest to compare the CCR5del32 allelic frequency found in HIV-infected persons to the same frequency in Bulgarian general population. The data about the Bulgarian population were published earlier by (21) and the comparison is shown on Table 2 .
The data show statistically signifi cant difference in CCR5del32 allelic frequency between HIV-infected (1.7%) and non-infected (7%) Bulgarians (p<0.05).
The exploring of zero-hypothesis (Н 0 ) for comparison of CCR5del32 allelic frequencies in persons, living with НІV and non-infected persons showed level of signifi cance lower than 0,05, so rejecting the lack of difference between the two compared groups originally postulated by the zero-hypothesis (H o ). In other words, this means that the allelic CCR5del32 frequency in non-infected persons is remarkably higher than in persons living with НІV. This conclusion, as well as the lack of homozygous (CCR5del32/CCR5del32) persons in the group of those living with НІV, confi rms and extends the signifi cance of genetic factors, responsible for the HIV insusceptibility. Fig. 3 represents an example of electrophoretic profi le of the amplifi cation product of the gene coding for SDF-1 after MspI restrictase treatment. The results for CXCR4 (SDF-1) genetic polymorphisms are shown on Table 3 .
CXCR4 (SDF-1) genetic polymorphisms
The data show a frequency of homozygous pattern (SDF-1 3'A/SDF-1 3'A) in persons living with HIV (7 out of 48, 14.58%) comparable to that in general population (9%) -p=0,3 According to them, so far there is no dependence of this homozygous status and the susceptibility to HIV. These data should be reviewed after computing on the basis of the threelocus genotype (CCR5del32, SDF-1 3'A and CCR2 V64I) for each individual studied (both infected and uninfected) and evaluation of relative hazard (RH) values. Additionally, higher frequency of homozygous pattern (SDF-1 3'A/SDF-1 3'A) in LTSs (27.3%) compared to the group of persons with moderate or rapid progression (10.81%) was observed, but without statistical signifi cance (p=0.2378), probably due to the low number of LTSs.
According to literature (22) , the homozygocity in SDF-1 (SDF -1 3'A/ SDF -1 3'A) only is most likely associated with better prognosis due to later AIDS onset and lower viral load. It is important to compare the distribution of SDF-1 3'A polymorphism in HIV(+) persons with slow progression to AIDS (45.8%) to that of the general Bulgarian population (26.5%) -there is a statistically signifi cant difference (p=0,04).The distribution of SDF -1 3'A in general population varies from population to population and Bulgaria has a relatively high, but within the parameters found (range 2.9% -36.6%), allele frequency (23) . Therefore, although low number of LTSs studied, their SDF-1 3'A polymorphism data confi rm those published.
To evaluate risk of AIDS onset and even for HIV infection for the Bulgarian population, the relative hazard (RH) value should be computed on the basis of three-locus genotype for each individual. The RH values for each of the possible threelocus genotypes should evaluate the expected insusceptibility to HIV and risk for AIDS onset from genetical point of view. Fig. 4 . represents an example of electrophoretic profi le of the amplifi cation product of the gene coding for CCR2 after BsaBI restrictase treatment.
CCR2 genetic polymorphisms
The results for CCR2 genetic polymorphisms are shown on Table 4 .
In the literature the signifi cance of CCR2-V64I genetic polymorphism alone is not completely clear. As seen, in our study there is no signifi cant difference by this defect between the group of rapid/moderate progressors to AIDS and LTSs (P=0.4414). However, it is well known that cases, where homozygocity in CCR2 V64I coexists with heterozygocity in CCR5 are associated with lower levels of viremia during early chronic HIV-1 infection (9). Moreover, patients with both defects show better response to HAART. So, further study of response to HAART in relation to genetic polymorphism of co-receptor genes seems worth doing. all three co-receptors, comparison of genetic patterns of LTS so far studied, has ben done ( Table 5) . As seen, 2 out of all 14 LTSs show heterozygous CCR5/ CCR5del32 pattern (Nos.1, 2, 3), including one displaying heterozygous SDF-1 /SDF-1 3'A pattern (No. 1). Another two (Nos. 7 and 8) display heterozygous CCR2/CCR2-V64I pattern. On the other hand, three LTSs (Nos. 4, 5, 6) show homozygous SDF-1 3'A/SDF-1 3'A pattern, none of them heterozygous for CCR5del32. Surprisingly, four LTSs (Nos. 9, 10, 11, 12) demonstrate heterozygous SDF-1/SDF-1 3'A pattern combined with wild type of the other two co-receptor genes. The only explanation for this could be the relatively high incidence of SDF-1 3'A allele in Bulgarian population.
After completing and publishing of the results obtained here together with the fi rst results of genetic polymorphism of CCR5 in population groups in Bulgaria (21) and in a little group of HIV-infected untreated LTSs (1) a recommendation could be drawn to evaluate risk of AIDS onset and even for HIV infection for the Bulgarian population, using the genetic data and respective RH values. Latter should be computed on the basis of three-locus genotype for each individual, separately for the general population and the HIV(+) persons. The RH values for each of the possible three-locus genotypes should evaluate the expected insusceptibility to HIV for the general population and risk for AIDS onset from the HIV-infected persons from genetical point of view.
Although referring to little number of HIV-infected people, the data obtained are in agreement with those published already. We feel encouraged in performing further studies to link the genetic polymorphisms of the three most often used co-receptors in HIV-infection to the response to HAART in the Bulgarians living with this infection.
